Detalhe da pesquisa
1.
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia.
Am J Hematol
; 96(4): 462-470, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502020
2.
Venetoclax-induced tumour lysis syndrome in acute myeloid leukaemia.
Br J Haematol
; 188(1): 173-177, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31621058
3.
Clinical features of schwannomatosis: a retrospective analysis of 87 patients.
Oncologist
; 17(10): 1317-22, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22927469
4.
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome.
Genet Med
; 14(12): 977-82, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22878510
5.
Acute Myeloid Leukemia with Co-mutated ASXL1 and SRSF2 Exhibits Monocytic Differentiation and has a Mutational Profile Overlapping with Chronic Myelomonocytic Leukemia.
Hemasphere
; 3(4): e292, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31942545
6.
Plasma S100ß is not a useful biomarker for tumor burden in neurofibromatosis.
Clin Biochem
; 46(7-8): 698-700, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23261835
7.
Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis.
PLoS One
; 7(4): e35711, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22558206